Gianni Sorarù

Clinical expert and Principal investigator of clinical trials

Dr. Gianni Sorarù is an associate professor of Neurology at the Department of Neuroscience of the University of Padova. He has always been interested in the field of motor neuron diseases. At the MND Clinic of Padova, he is responsible for the multidisciplinary team. His research activity aims to integrate information derived from laboratory studies with clinical applications. In the context of national and international collaborations, he actively conducts clinical trials and participates in the creation of working groups, patient registries and biobanks.

Connect
Connect trials
Active
Phase ii

RT001 in Amyotrophic Lateral Sclerosis

Industry trial

In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS. This clinical trial is sponsored by Retrotope Inc.

Read more
Active
Phase iii

ALXN1210-ALS-308 trial

Industry trial

This phase 3 trial aims to study the safety and efficacy of the drug ‘ravulizumab’ in people living with ALS. To register for this study, you should contact your local ALS centre or treating physician.

Read more
Active
Phase iii

VALOR study

Industry trial

Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS) with a SOD1 gene mutation.

Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial

This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.

Read more